Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000658694 | SCV000780480 | uncertain significance | not provided | 2018-02-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002534294 | SCV003300132 | uncertain significance | Emery-Dreifuss muscular dystrophy 5, autosomal dominant | 2022-10-17 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln678Thrfs*7) in the SYNE2 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in SYNE2 cause disease. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 546740). This variant has not been reported in the literature in individuals affected with SYNE2-related conditions. This variant is present in population databases (rs750736888, gnomAD 0.003%). |